Tempus (formerly Arterys)
About Tempus (formerly Arterys)
Tempus is a leading healthcare technology company that leverages artificial intelligence (AI) and a vast library of multimodal data to advance precision medicine. Founded with the mission to make healthcare more data-driven, Tempus has built an operating system designed to liberate healthcare data from silos and make it actionable for physicians and researchers. This platform integrates various data modalities, including genomic sequencing, clinical records, pathology slides, and radiology images, to provide a comprehensive view of each patient.
For physicians, Tempus offers Intelligent Diagnostics that utilize AI, including generative AI, to enhance the accuracy, tailoring, and personalization of laboratory tests. The company’s AI-enabled platform contextualizes results for individual patients, aiding in personalized treatment decisions. Tempus also provides tools like ‘ONE’ for ordering and managing tests, ‘NEXT’ to identify and close gaps in care, and ‘LENS’ for researchers to analyze real-world data and build cohorts.
Tempus’s capabilities have been significantly expanded through strategic acquisitions, notably the integration of Arterys in October 2022. This acquisition brought Arterys’ AI platform for medical imaging, including FDA-cleared solutions for analyzing various scans like lung CTs, chest X-rays, and cardiac MRIs, into Tempus’s offerings. This allows for a more holistic patient view encompassing radiology images alongside molecular and clinical data, further strengthening Tempus’s role in powering drug discovery, genomic sequencing, and clinical trials.
Focus Areas
Business Intelligence
| Key Investors | SoftBank Group, Baillie Gifford, New Enterprise Associates (NEA), Novo Holdings, Franklin Templeton Investments, T. Rowe Price, Revolution LLC, Google LLC, Ares Management, ARK Investment Management LLC, BlackRock, Inc., Vanguard Group Inc. |
| Partnerships | ARPA-H, SoftBank (Japan JV), GSK, AstraZeneca, Predicta Biosciences, Gilead, Medtronic, Illumina, Daiichi Sankyo, IFLI |
| Acquisitions | Arterys (2022), Highline Sciences (Feb 2022), Mpirik (Mar 2023), Ambry Genetics (Nov 2024, $600M), Deep 6 AI (Mar 2025), Paige (Aug 2025, $81.2M) |
| Technology | Tempus Platform (data ingestion, harmonization, structuring, diagnostic testing, AI-enabled analytics), AI operating system, generative AI, multimodal data (NGS, anatomic pathology, radiology, EHR data). Key products include Tempus ONE (AI-enabled assistant), NEXT (care pathway intelligence), LENS (real-world data analytics), ALGOS (algorithmic models), Tempus xR IVD (RNA NGS), Tempus Pixel (cardiac imaging), Tempus ECG-AF (AFib risk), Tempus ECG-Low EF (LVEF detection), TIME Trial Program, Olivia (patient app). |
| FDA Clearances | 4+ (8 from acquired Arterys) cleared products (estimated) |
What Physicians Need to Know
For physicians, Tempus stands out by offering a comprehensive, AI-driven platform that integrates molecular, clinical, pathology, and radiology data into a single view, enabling more personalized and informed treatment decisions. Utilize **Tempus Hub** for a centralized portal to order tests, review results, track biomarkers longitudinally, and identify clinical trial opportunities. Leverage **Tempus One**, their generative AI assistant, for quick, voice-enabled access to patient-specific summaries and guideline integration, reducing cognitive load during patient interactions. Explore the 'Patient Similarities' and 'Consults' features within Hub for peer collaboration and insights from similar cases. For imaging, **Tempus Pixel** provides AI-enhanced analysis for cardiology and radiology, improving diagnostic accuracy and efficiency. The 'Refresh' feature ensures you always have the latest therapeutic options and clinical trial matches based on evolving data and guidelines.
Tempus prioritizes seamless integration with existing healthcare systems, including deep **EHR integrations** (e.g., Epic, ASCO's CancerLinQ). This allows their AI-enabled tools and data to be directly accessible within clinical workflows, minimizing data silos and enhancing interoperability. The **Tempus Hub** platform is accessible on both mobile and desktop, providing flexibility for physicians to engage with patient data and insights from various devices. This integrated approach aims to embed precision medicine directly into routine clinical practice.
What the Web Says
Tempus (formerly Arterys) is a company focused on AI-driven precision medicine, particularly in oncology and medical imaging. While their products, such as the AI platform for medical imaging and genomic profiling assays, are generally viewed as innovative and impactful for patient care, employee reviews paint a mixed picture of the company culture and management. There are also some concerns regarding customer service and billing practices for their testing services.
Overall: MixedStrengths
- AI-enabled precision medicine and innovative technology.
- Products aim to improve patient care and outcomes, especially in oncology.
- Seamless integration into existing clinical tools and workflows.
- Collaborative and intellectually stimulating work environment (reported by some employees).
- Good benefits and PTO (reported by some employees).
- Strong funding and clinical partnerships.
Limitations
- Mixed to negative employee reviews regarding management and culture.
- Poor work-life balance and employees often stretched thin.
- Low pay and benefits, including no 401K matching (reported by some employees).
- Lack of job security and advancement opportunities, with promotions based on tenure rather than merit.
- Customer service issues, including unresponsiveness and billing problems.
- Disorganization and lack of transparency from management.
Based on reviews from: Indeed.com, Tempus.com, Spotsaas.com, SoftwareWorld.com, AIToolsBox.com, Nebula Genomics, Trustpilot.com, G2.com, Reddit.com, Capterra.com, Slashdot.org, JobzMall.com, BuiltIn.com, AI Suggests, Dennis Gong
Last updated: 2026-07-17
Videos
News, demos, and interviews about Tempus (formerly Arterys).
Videos load interactively. If none appear, search YouTube for Tempus (formerly Arterys) →
Press & Coverage
Frequently Asked Questions
Comparisons
Related Companies
Intelligent Voice AI (IVAI) is an agentic AI platform that deploys AI voice agents specifically designed for healthcare, insurance, legal, and home services businesses. For physicians and medical practices, IVAI’s Evolve AI Agents act as an AI workforce, not just an answering service, handling a comprehensive range of administrative and operational tasks. These agents can […]
Dext, formerly known as Receipt Bank, is a company that specializes in bookkeeping automation, leveraging data, technology, and applied AI to enhance productivity and efficiency for businesses, accountants, and bookkeepers. [3, 16] Their platform is designed to streamline financial document management and automate bookkeeping tasks, aiming to simplify the accounting process and enable more informed […]
Cortex (https://www.cortex.app) is an AI-powered internal developer portal designed to enhance engineering excellence and streamline software development workflows. For physicians, this translates to a platform that can indirectly improve healthcare technology by enabling engineering teams to build more reliable, secure, and efficient software. The platform helps in cataloging, scoring, and assigning actions to improve service […]
Nino is an AI-powered financial planning and tax service that aims to provide comprehensive financial guidance. For physicians, Nino’s AI software can help manage income, student loans, and plan career transitions, such as moving from training to practice or considering practice ownership. The platform allows physicians to view loans, income, and savings in one place, […]
Coral AI is a healthcare artificial intelligence company that aims to streamline administrative workflows for healthcare providers, ultimately accelerating patient access to care. The company’s AI-driven platform integrates with existing healthcare systems, including EHRs, fax lines, and payer portals, to automate complex administrative tasks. This includes patient intake, prior authorizations, billing, compliance, and patient outreach. […]
SamaCare is a healthcare AI company that provides a cloud-based workflow intelligence platform designed to streamline the prior authorization process for specialty medications. The company’s platform aims to reduce the administrative burden on medical practices, improve approval rates, and add predictability to patient care. By digitizing the often manual and paper-heavy prior authorization process, SamaCare […]